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botulinum toxin injection to the esophagus
Timothy P. Shiraev, MB, BS (Hons), BSc (Hons),a Trevor M. Y. Kwok, MB, BS,a
Saissan Rajendran, MB, BS, MS,b John P. Gan, MB, BS, FRACS,b and Rafﬁ A. Qasabian, MB, BS, FRACS,a
Sydney and Port Macquarie, New South Wales, Australia
Aortic pseudoaneurysms are uncommon and are usually secondary to penetrating trauma. We describe the presentation
and management of an elderly woman who suffered a pseudoaneurysm of the descending thoracic aorta several days after
receiving botulinum toxin injection to the esophagus. Urgent thoracic endovascular aortic repair was performed, and
long-term antibiotic therapy was commenced. Despite a slow initial clinical recovery, she returned to an independent
lifestyle, with radiographic resolution of the pseudoaneurysm seen at follow-up. This case illustrates that endovascular
aortic repair is a suitable and safe treatment option for this unusual presentation. (J Vasc Surg Cases 2016;2:126-9.)Aortic pseudoaneurysms are an uncommon pathologic
process whose etiology includes iatrogenic causes,1-3
trauma,4,5 infection,6 and vasculitis.7 Numerous manage-
ment options have been described, including percutaneous
or endovascular thrombin injection,8,9 thoracic endovascu-
lar aortic repair (TEVAR),1 and open surgical repair.4,10
This case demonstrates the unusual occurrence of an aortic
pseudoaneurysm developing secondary to botulinum toxin
injection for esophageal spasm and its treatment with
TEVAR. The patient’s consent was obtained for publica-
tion of this case report.
CASE REPORT
A 92-year-old woman presented to a rural hospital with fevers
and chest pain 12 days after she received botulinum toxin injection
to the lower esophageal sphincter (LES) through esophagoscopy
for treatment of esophageal spasm. Her background medical
history included hypertension, gastroesophageal reﬂux, and
peripheral neuropathy. She was not taking any anticoagulant
agents. Her leukocyte count was normal (10.8  109/L; reference
range, 4.0-11.0  109/L), but C-reactive protein concentration
was elevated (270 mg/L; reference range, <6 mg/L). A provi-
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culture grew Gemella species, a commensal of the gastrointestinal
tract. Her chest pain persisted. Plain radiography of the chest
demonstrated a widened mediastinum. Contrast-enhanced
computed tomography (CT) of the chest was therefore performed;
it demonstrated a pseudoaneurysm of the descending aorta at the
level of the 11th and 12th thoracic vertebrae, with a large medias-
tinal hematoma, and extravasation of contrast material in the arte-
rial phase (Fig 1).
The patient was transferred by air ambulance to our institu-
tion, a metropolitan tertiary referral hospital, a distance of
400 km. In view of the blood culture result, she was given intrave-
nous penicillin G. Shortly after arrival, she was taken to the hybrid
operating room for angiography and treatment. Under general
anesthesia, percutaneous access to both common femoral arteries
was obtained with two Perclose ProGlide (Abbott Vascular,
Abbott Park, Ill) closure devices placed in the right groin. Aortog-
raphy demonstrated active blush 5 cm proximal to the origin of the
celiac trunk (Fig 2, A). Intraoperative heparin was not adminis-
tered as the patient’s international normalized ratio was
1.9 (normal range, 0.9-1.2). A Conformable TAG stent graft
(W. L. Gore & Associates, Newark, Del; diameter, 26 mm; length,
100 mm) was introduced through the right groin and deployed in
the thoracic aorta, covering the identiﬁed site of extravasation.
Angiography conﬁrmed satisfactory stent placement and successful
exclusion of the pseudoaneurysm (Fig 2, B). Hemostasis was
achieved in the right groin by completion of deployment of the
Perclose ProGlide device and in the left groin by deployment of
a StarClose closure device (Abbott). Postoperatively, she was taken
to the intensive care unit for monitoring.
The patient’s recovery after TEVAR was marked by ongoing
dyspnea. Repeated thoracic CT on postoperative day 3 conﬁrmed
successful treatment of the pseudoaneurysm (Fig 3) and estab-
lished ﬂuid overload, pleural effusion, and the remaining medias-
tinal hematoma as likely causes of the dyspnea. Consultation of
the cardiothoracic surgery service was obtained, and it was advised
that percutaneous drainage of the hematoma would be high risk
and therefore inappropriate. As a precaution, on postoperative
day 6, the patient was taken for esophagogastroduodenoscopy,
which showed some indentation of the midesophagus, likely due
Fig 1. Preoperative computed tomography (CT) aortogram
demonstrating the pseudoaneurysm (arrow) with associated
mediastinal hematoma. A, Sagittal view. B, Axial view.
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mucosal defect, ulceration, or necrosis was seen in the esophagus.
In light of the patient’s positive blood culture, transthoracic
echocardiography was performed to assess for evidence of infective
endocarditis, but it was inconclusive. Whereas usually the next
investigation in this situation would be transesophageal echocardi-
ography, this was deemed unsafe, given the extrinsic compression
demonstrated on esophagogastroduodenoscopy. Given theinfective nature of the pseudoaneurysm, the inability to exclude
infective endocarditis, and the presence now of an endovascular
graft, the patient was continued on intravenous penicillin G for
6 weeks, after which she was prescribed lifelong oral amoxicillin.
Because of her slow clinical recovery, the patient remained
admitted at our institution until postoperative day 18, when she
was transferred back to the referring rural hospital. Subsequently,
she developed worsening dyspnea and was diagnosed with left
lower limb deep venous thrombosis and pulmonary embolism,
which were treated with warfarin. Despite this, she recovered
well, and 5 weeks after the initial presentation, she was transferred
to a lower acuity facility for a period of rehabilitation. After this,
she was discharged home, where she was able to resume living
independently.
At 3-month clinical review, the patient was asymptomatic and
continuing to improve her functional capacity. Follow-up CT of
the chest demonstrated good resolution of the pseudoaneurysm,
with no evidence of ongoing infection (Fig 4).
DISCUSSION
The cause of most pseudoaneurysms of the descending
thoracic aorta is trauma.6 Iatrogenic pseudoaneurysms are
usually secondary to lumbar disk surgery, through either
an anterior or posterior approach, with an incidence of
1 to 5 per 10,000 operations.2,10 A case of an inferior
vena cava ﬁlter causing pseudoaneurysm of the abdominal
aorta has also been reported.1 Interestingly, in a reported
case similar to ours, pseudoaneurysm of the abdominal
aorta formed after a nerve-blocking procedure to the celiac
plexus, with culture of the aortic wall also growing a gastro-
intestinal commensal, which was treated with open surgical
repair by a thoracoabdominal approach.3
Achalasia, a motility disorder secondary to increased
LES tone, can be managed with myotomy, pneumatic
dilation, or botulinum toxin injection into the LES.11
Botulinum injection is not commonly performed,11 but it
can be used in patients whose comorbidities preclude
more invasive options.12 In the procedure, 100 units of
botulinum toxin A are injected in all four quadrants of
the esophageal sphincter (using the squamocolumnar
junction as a landmark) at esophagoscopy.13 Delivery is
usually quite precise, with one study demonstrating that
100% of injections were delivered into either the submu-
cosa or muscle layer.14 Our patient underwent botulinum
toxin injection for reﬂux symptoms, and although she
had been discharged after that procedure with no issues
noted, she subsequently developed a thoracic aortic
pseudoaneurysm, a complication to our knowledge not
previously reported. Vascular surgeons and gastroenterolo-
gists should therefore be aware of this unusual but
potentially lethal complication. One technique to prevent
such an occurrence is drawing back on the syringe before
injecting to ensure that the needle tip is not in a vascular
structure. It may also be beneﬁcial to obtain a plain radio-
graph shortly after botulinum injection to exclude compli-
cations such as mediastinal hematoma and pneumothorax.
Furthermore, knowledge of this complication should alert
clinicians to have a low threshold for further investigations
Fig 2. Intraoperative aortograms. A, The pseudoaneurysm (arrow) is seen arising proximal to the celiac trunk. B, After
deployment of the stent graft, successful exclusion of the pseudoaneurysm is demonstrated.
Fig 3. Postoperative computed tomography (CT) angiogram
demonstrates resolution of the pseudoaneurysm but with signiﬁ-
cant persistent mediastinal hematoma (arrow).
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botulinum toxin injection. Our patient was successfully
treated with stent grafting, as has been previously described
for traumatic aortic pseudoaneurysms.1,5
Besides TEVAR, described treatments for aortic pseu-
doaneurysms include thrombin injection and open surgical
repair. As many vascular surgeons’ experience with aortic
stent grafting has rapidly grown during recent years,
TEVAR can now be performed in many centers more
quickly and more safely than either thrombin injection or
open surgical repair. This is particularly true in centers
where a hybrid operating room is available. In addition,
because TEVAR covers the arterial defect with a stent graft,
it may reduce the risk of postoperative rebleeding, which is
a consideration in patients such as ours who required anti-
coagulation during her recovery.
CONCLUSIONS
This case highlights aortic pseudoaneurysm as a
possibly under-recognized potential serious complication
Fig 4. Computed tomography (CT) angiogram at 3-month
follow-up demonstrating resolution of mediastinal hematoma,
with no recurrence of pseudoaneurysm.
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demonstrates TEVAR as a useful and effective treatment
for this pathologic process, which can be performed
rapidly in a suitably equipped facility. The patient will
require long-term follow-up as well as lifelong oral anti-
biotics to reduce the risk of endograft infection.REFERENCES
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